An observational study in Type 2 Diabetes and Impaired Glucose Intolerance, sponsored by Yonsei University. Not yet recruiting. Open to participants aged 20 Years to 100 Years. Per ClinicalTrials.gov, last updated 2016-04-18.
Sponsored by Yonsei University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 20 studies in Diabetes Mellitus, Type 2 by Yonsei University — 5 open to participants now, 6 under way, none of them phase 3. Diabetes Mellitus, Type 2 · Yonsei University.
Among the 20 studies in Diabetes Mellitus, Type 2 by Yonsei University, this one is the only one that started in 2007, is one of 7 observational ones, and was the 8th registered.
10,403 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.
Browse Diabetes Mellitus, Type 2 studies →5 of the 20 studies in Diabetes Mellitus, Type 2 by Yonsei University are open now, in 1 country. Recruiting first, the newest first:
Yonsei University · Sites in Korea, Republic of
Ages 19+
Yonsei University · Sites in Korea, Republic of
Ages 50+
Yonsei University · Sites in Korea, Republic of
Ages 19–75
Yonsei University · Sites in Korea, Republic of
Ages 20+
By country, each count listing its studies:
Of the 882 Diabetes Mellitus, Type 2 studies recruiting now, 372 (42%) set no upper age limit and 384 (44%) stop at 75 or younger; 52 take children under 18; 202 take healthy volunteers.
This study: 20 Years to 100 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
20 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 1 started in 2007.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 500 is above the median of 300 across 1,749 observational studies indexed under Diabetes Mellitus, Type 2.
Median enrollment 61 across the 13 interventional studies, 431 across the 6 observational. Of the 11 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Yonsei University is the lead sponsor of 1,421 studies on the registry; 241 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 20 studies in Diabetes Mellitus, Type 2 by Yonsei University, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The prevalence of type 2 diabetes has consistently increased and type 2 diabetes can cause many types of vascular complications. Diabetes develops due to glucose intolerance. Early detection and intervention in the stage of glucose intolerance makes it afford to prevent overt diabetes and its complications. This study was designed to make a cohort of korean patients with glucose intolerance to construct a long term database about clinical characteristics of these patients.
Patients with either type 2 diabetes or impaired glucose toloerance who are older than 20 years old and have attended Gangnam Severance hospital for regular follow up.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients with either type 2 diabetes or impaired glucose tolerance who are older than 20 years old and have attended Gangnam Severance hospital for regular follow up.
Life style assessment - Past medical history - Smoking, alcohol history - Sleep, exercise, daily activity check - Diet - Reproductive status (Women only) - Socioeconomic status
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Time frame: an expected average of 12 weeks
Past medical history
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Time frame: an expected average of 12 weeks
Smoking, alcohol history
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Time frame: an expected average of 12 weeks
Sleep, exercise, daily activity check
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Time frame: an expected average of 12 weeks
Diet
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Time frame: an expected average of 12 weeks
Reproductive status (Women only)
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Time frame: an expected average of 12 weeks
Socioeconomic status
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Time frame: an expected average of 12 weeks
Anthropometric measurements : Height, weight, waist circumference, pulse rate, blood pressure
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Time frame: an expected average of 12 weeks
SMA, TG, HDL, LDLM apoA, apoB
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Time frame: an expected average of 12 weeks
PC2hrs, HbA1C, Insulin, C-peptide (AC, PC2hr), hs-CRP
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Time frame: an expected average of 12 weeks
Urine protein, albumin, creatinine
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Time frame: an expected average of 12 weeks
EKG, Neurometer, Chest PA, Abdominal sonography
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Time frame: an expected average of 12 weeks
Fundus photography, fat computed tomography
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Time frame: an expected average of 12 weeks
HOMA-IR, HOMA-β
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Time frame: an expected average of 12 weeks
No study locations are listed for this record.
Plan to share: Yes — This study has a plan to share data
No publications or documents are linked to this record.
The record gives a start of Jan 2007, a primary completion of Feb 2026 and a completion of Feb 2026. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.